跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
DEFERASIROX-TEVA deferasirox 360 mg film-coated tablet blister pack
Approved
STANDARD
DEFERASIROX-TEVA deferasirox 360 mg film-coated tablet blister pack
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0b09805c5dd9caa6
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
0b09805c5dd9caa6
Product Name
DEFERASIROX-TEVA deferasirox 360 mg film-coated tablet blister pack
Artg Id
350822
Artg Name
DEFERASIROX-TEVA deferasirox 360 mg film-coated tablet blister pack
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2021-08-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/1d94a11e3bb33994de89b7c7b780adf1.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6c61d94c65ac66c114c180c66a4ff776.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0b09805c5dd9caa6
Type
Standard
Back to TGA Approvals
DEFERASIROX-TEVA deferasirox 360 mg film-coated tablet blister pack - TGA Drug Approval Details
